Relationship between Eicosanoids and Endothelin-1 in the Pathogenesis of Erythropoietin-induced Hypertension in Uremic Rats
- 1 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 41 (3) , 388-395
- https://doi.org/10.1097/00005344-200303000-00007
Abstract
Recent studies suggest a possible link between recombinant human erythropoietin (rhEPO)-induced hypertension and endothelium-derived vasoconstrictor autocoids. The current study was designed to evaluate the role of eicosanoids such as thromboxane (TX) A2 and prostacyclin (PGI2) and of endothelin-1 (ET-1) and the relationship between these vasoactive substances in rhEPO-induced hypertension in uremic rats. Renal failure was induced by a two-stage 5/6 nephrectomy followed by a 6-week stabilization period. In protocol A, rats were divided into four groups: vehicle, rhEPO (100 u/kg, subcutaneously, three times per week), a selective ETA receptor antagonist (ABT-627, 10 mg/kg/d), and rhEPO + ABT-627 for 5 weeks. In protocol B, uremic animals were divided into two groups: rhEPO and rhEPO + a TX receptor antagonist and synthesis inhibitor, ridogrel (25 mg/kg/d), for 5 weeks. At the end of the study, immunoreactive eicosanoid metabolites (TXB2 and 6-keto-PGF1α, stable metabolites of TXA2 and PGI2), and ET-1 were measured in either the thoracic aorta or in the mesenteric arterial bed. After 5/6 nephrectomy, the animals developed uremia, anemia, and hypertension. rhEPO corrected the anemia but aggravated the hypertension. Both drugs were effective in preventing the progression of hypertension in rhEPO-treated rats although ABT-627 was more potent than ridogrel. rhEPO increased the concentration of ET-1 and TXB2 in blood vessels and ABT-627 decreased tissue levels of both vasopressors. The concentration of 6-keto-PGF1α was not significantly changed. Ridogrel significantly decreased tissue TXB2 concentrations but had no effect on ET-1 levels. These results suggest that endothelium-derived vasoconstrictor autacoids (TXA2 and ET-1) are involved in the pathogenesis of rhEPO-induced hypertension in uremic rats. TXA2 probably serves as a mediator of the vascular effect of ET-1.Keywords
This publication has 39 references indexed in Scilit:
- Erythropoietin upregulates angiotensin receptors in cultured rat vascular smooth muscle cellsJournal Of Hypertension, 1998
- Uremia Enhances the Blood Pressure Response to ErythropoietinClinical and Experimental Hypertension, 1997
- Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients*American Journal of Hypertension, 1995
- Erythropoietin receptor mRNA expression in human endothelial cells.Proceedings of the National Academy of Sciences, 1994
- Intracellular pH on adrenergic-stimulated cAMP and cGMP production in rat pinealocytesAmerican Journal of Physiology-Cell Physiology, 1991
- Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy menJournal of Internal Medicine, 1991
- Hypertension Following Erythropoietin Therapy in Anemic Hemodialysis PatientsAmerican Journal of Hypertension, 1990
- Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritisThe American Journal of Medicine, 1990
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990